Our core formulation development capabilities across all dosage forms:
Solid Dosage Forms: We possess R&D and industrialization expertise for diverse solid formulations, including tablets, capsules, granules, sustained- and controlled-release systems, and orally dissolving films.
Liquid Dosage Forms: Our capabilities span conventional liquids such as oral solutions, injectables (liquid vials/lyophilized powders), and eye/ear drops, as well as advanced development of complex injectables including nanocrystals and liposomes.
Semi-Solid Dosage Forms (Topical/Transdermal): We have extensive experience and technical know-how in developing topical formulations, including gels, creams, ointments, patches, and medicated plasters.
Pre-Clinical Research
Pharmaceutical Development
We deliver excellence across innovative drugs, complex formulations, and generics, providing comprehensive, end-to-end pharmaceutical research services powered by our specialized expertise.
Pharmaceutical Development
INTRODUCTION
Focuses on pharmaceutical development, specializing in innovative drugs with intellectual property, complex preparations, and high-quality generic drugs. Our experience covers multiple therapeutic areas, including oncology, peptides, and cardiovascular.
Our Capabilities
Project Experience
-
40+
Contract research project completed
-
30+
Production and clinical trials for customers approved
- To date, we have completed over 40 projects, including contract research and proprietary self-initiated R&D projects, and have secured more than 30 approvals for our clients covering production and clinical trials.
- We have established proven expertise and delivered tangible outcomes in innovative drug development, complex formulations, and high-quality generic drug projects.
Formulation development
Preformulation Services
Process Development
Quality Analysis and
Fommulation Services
Technology Transfer
and Process Scale-Up
CMO services
Stability Testing
Service Features
Complex Injection Platform
Nanosuspensions offer an alternative formulation strategy for such compounds, effectively addressing poor bioavailability by enhancing drug dissolution and thereby improving pharmacokinetic performance.
Our formulation team possesses extensive, end-to-end experience in nanoscale preparation, characterization, regulatory submission, and commercial-scale manufacturing of poorly soluble drugs.
Our formulation team possesses extensive, end-to-end experience in nanoscale preparation, characterization, regulatory submission, and commercial-scale manufacturing of poorly soluble drugs.
Eye Drop Formulation Platform
Eye drops are one of the most widely used dosage forms for ophthalmic diseases, offering direct and rapid therapeutic effects for a variety of ocular conditions, with distinct clinical advantages.
We have extensive experience in key areas including reducing ocular irritation, developing preservative-free alternatives, and integrating formulation technology with ocular physiology to enhance the safety and efficacy of drug delivery. Several of our projects in this field have progressed to industrial-scale production.
We have extensive experience in key areas including reducing ocular irritation, developing preservative-free alternatives, and integrating formulation technology with ocular physiology to enhance the safety and efficacy of drug delivery. Several of our projects in this field have progressed to industrial-scale production.
Inhalation Formulation Platform
Inhaled formulations provide distinct advantages over other routes of administration in respiratory disease treatment, delivering drugs directly to the site of action for rapid absorption, avoiding first-pass metabolism, and improving bioavailability with lower doses.
Supported by seasoned experts and advanced facilities, this platform has leveraged years of research and experience to advance multiple projects to regulatory submission.
Supported by seasoned experts and advanced facilities, this platform has leveraged years of research and experience to advance multiple projects to regulatory submission.
Sustained-release Formulation Platform
Sustained-release formulations provide key advantages for drugs with short half-lives or requiring frequent dosing. They reduce dosing frequency, maintain stable plasma concentrations to minimize peak-and-trough fluctuations, lower the risk of adverse effects, and enable optimal efficacy with reduced total drug exposure.
Our team is dedicated to advancing extended-release technologies and has achieved significant success, with multiple projects having gained regulatory approval.
Our team is dedicated to advancing extended-release technologies and has achieved significant success, with multiple projects having gained regulatory approval.